Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-039038
Filing Date
2025-03-14
Accepted
2025-03-13 20:01:04
Documents
155
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 20-F clls-20241231.htm   iXBRL 20-F 9195648
2 EX-1.1 clls-ex1_1.htm EX-1.1 157238
3 EX-2.3 clls-ex2_3.htm EX-2.3 403789
4 EX-4.4 clls-ex4_4.htm EX-4.4 210984
5 EX-4.34 clls-ex4_34.htm EX-4.34 727429
6 EX-8.1 clls-ex8_1.htm EX-8.1 4622
7 EX-11.1 clls-ex11_1.htm EX-11.1 155204
8 EX-12.1 clls-ex12_1.htm EX-12.1 14530
9 EX-12.2 clls-ex12_2.htm EX-12.2 14502
10 EX-13.1 clls-ex13_1.htm EX-13.1 6612
11 EX-13.2 clls-ex13_2.htm EX-13.2 7439
12 EX-15.1 clls-ex15_1.htm EX-15.1 5600
13 EX-15.2 clls-ex15_2.htm EX-15.2 10611
14 EX-97.1 clls-ex97_1.htm EX-97.1 62515
15 GRAPHIC img30446261_0.jpg GRAPHIC 78633
16 GRAPHIC img109707964_0.jpg GRAPHIC 210180
17 GRAPHIC img109707964_1.jpg GRAPHIC 44081
18 GRAPHIC img109707964_2.jpg GRAPHIC 24358
19 GRAPHIC img109707964_3.jpg GRAPHIC 15647
20 GRAPHIC img109707964_4.jpg GRAPHIC 22627
21 GRAPHIC img109707964_5.jpg GRAPHIC 729137
22 GRAPHIC img109707964_6.jpg GRAPHIC 23161
23 GRAPHIC img109707964_7.jpg GRAPHIC 26601
24 GRAPHIC img109707964_8.jpg GRAPHIC 30112
  Complete submission text file 0000950170-25-039038.txt   40708986

Data Files

Seq Description Document Type Size
25 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT clls-20241231.xsd EX-101.SCH 3442249
158 EXTRACTED XBRL INSTANCE DOCUMENT clls-20241231_htm.xml XML 9308884
Mailing Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013
Business Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013 33181691600
Cellectis S.A. (Filer) CIK: 0001627281 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36891 | Film No.: 25737330
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)